Search

Your search keyword '"Kalnapenkis, A."' showing total 38 results

Search Constraints

Start Over You searched for: Author "Kalnapenkis, A." Remove constraint Author: "Kalnapenkis, A."
38 results on '"Kalnapenkis, A."'

Search Results

2. Genetic determinants of plasma protein levels in the Estonian population

3. Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets

4. Author Correction: Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets

5. Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals

6. OTTERS:a powerful TWAS framework leveraging summary-level reference data

7. Genetics of circulating inflammatory proteins identifies drivers of immune-mediated 22 disease risk and therapeutic targets

8. Mapping pQTLs of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and novel therapeutic targets

9. Identification of 371 genetic variants for age at first sex and birth linked to externalising behaviour

10. Genetic landscape of the ACE2 coronavirus receptor

11. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression

12. Mapping genetic determinants of 184 circulating proteins in 26,494 individuals to connect proteins and diseases

13. Genome-wide association analyses of risk tolerance and risky behaviors in over 1 million individuals identify hundreds of loci and shared genetic influences

14. Mendelian randomisation identifies alternative splicing of the FAS death receptor as a mediator of severe COVID-19

15. Mapping genetic determinants of 184 circulating proteins in 26,494 individuals to connect proteins and diseases

16. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression

17. Mendelian randomisation identifies alternative splicing of the FAS death receptor as a mediator of severe COVID-19

18. Refining Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder Genetic Loci by Integrating Summary Data From Genome-wide Association, Gene Expression, and DNA Methylation Studies

19. Genomic evaluation of circulating proteins for drug target characterisation and precision medicine

20. Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals

21. Refining Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder Genetic Loci by Integrating Summary Data From Genome-wide Association, Gene Expression, and DNA Methylation Studies

22. Genomic evaluation of circulating proteins for drug target characterisation and precision medicine

23. Genomics of 1 million parent lifespans implicates novel pathways and common diseases and distinguishes survival chances

24. Mendelian randomization integrating GWAS and eQTL data reveals genetic determinants of complex and clinical traits

25. Identifying gene targets for brain-related traits using transcriptomic and methylomic data from blood

26. Author response: Genomics of 1 million parent lifespans implicates novel pathways and common diseases and distinguishes survival chances

27. Unraveling the polygenic architecture of complex traits using blood eQTL metaanalysis

28. Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes

29. Analytical strategies to include the X-chromosome in variance heterogeneity analyses: evidence for trait-specific polygenic variance structure

31. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression

33. Naiste viljakusega seotud tunnuste geneetilised korrelatsioonid

35. Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals

36. C-reactive protein upregulates the whole blood expression of CD59 - an integrative analysis

37. Genetic Landscape of the ACE2 Coronavirus Receptor.

38. Mendelian randomisation identifies alternative splicing of the FAS death receptor as a mediator of severe COVID-19.

Catalog

Books, media, physical & digital resources